Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2007
12/21/2007WO2007121721A3 Therapeutic target molecules for the development of novel medicaments for degenerative diseases
12/21/2007WO2007116278A3 Antiangiogenic peptide and therapeutic uses thereof
12/21/2007WO2007116276A3 Integrin binding rgd-lipopeptides with gene transfer activities
12/21/2007WO2007101146A3 Selective vpac2 receptor peptide agonists
12/21/2007WO2007095347A3 Methods and compositions related to ghs-r antagonists
12/21/2007WO2007093177A3 Metallothionein-derived peptide fragments
12/21/2007WO2007081975A3 Method of treating multiple sclerosis
12/21/2007WO2007076505A3 Transferrin and transferrin-based compositions for diabetes treatment
12/21/2007WO2007064997A3 Compounds and methods for inhibiting apoptosis
12/21/2007WO2007059435A3 Compositions and methods for enhancing cognitive function
12/21/2007WO2007056540A3 Tnf-alpha blocker treatment for enterocolitis associated with immunostimulatory therapeutic antibody therapy
12/21/2007WO2007033444A3 Antiviral therapy with carbohydrate binding agents
12/21/2007WO2007011595A3 Neural regeneration peptides and antioxidants protect neurons from degeneration
12/21/2007WO2006134148A3 Transglutaminase mediated conjugation of growth hormone
12/21/2007WO2006116949A8 A new bacillus subtilis strain and its use in preparing medicine for treating thrombosis
12/21/2007WO2005123110A3 Compositions comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof
12/21/2007WO2005110455A3 Combination therapy for treating hepatitis virus infection
12/21/2007WO2005023193A3 Methods of treating endometriosis
12/21/2007WO2004071405A3 Lactate dehydrogenase: a target and reagent for diabetes therapy
12/21/2007WO2004069178A3 Anti-inflammatory activity from lactic acid bacteria
12/21/2007WO2004026189A3 Collagen-based materials and methods for augmenting intervertebral discs
12/21/2007WO2003064613A3 Amidases, nucleic acids encoding them and methods for making and using them
12/21/2007WO2003063903A3 Modulation of t lymphocytes using dp iv inhibitors
12/21/2007CA2835369A1 Peptide fragments for inducing synthesis of extracellular matrix proteins
12/21/2007CA2659097A1 Novel methods for ester detoxication
12/21/2007CA2657949A1 Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses
12/21/2007CA2657948A1 Denatured collagen peptides and uses thereof
12/21/2007CA2655565A1 Dph2 gene deletion mutant and uses thereof
12/21/2007CA2655488A1 Simultaneous, separate or sequential therapeutic use of at least one botulinum neurotoxin and of at least one opiate derivative
12/21/2007CA2655362A1 Compositions and methods for diagnosing and treating cancer
12/21/2007CA2655361A1 Sparc-derived tumor rejection antigenic peptides and medicaments comprising the same
12/21/2007CA2655116A1 Peptide fragments for inducing synthesis of extracellular matrix proteins
12/21/2007CA2654956A1 Peptides with anti-proliferative activity
12/21/2007CA2654944A1 Stabilized insulin-like growth factor polypeptides
12/21/2007CA2654566A1 Solid oral dosage form containing an enhancer
12/21/2007CA2654565A1 Topical treatment for diseases of eye surface
12/21/2007CA2654207A1 Insulin composition
12/21/2007CA2654055A1 Albumin fusion proteins
12/21/2007CA2653157A1 Induction of tolerance to egg proteins
12/21/2007CA2652516A1 Use of thymosin alpha 1 for preparing a medicament for the treatment of stage iv malignant melanoma
12/21/2007CA2651684A1 Peptide compounds for treating refractory status epilepticus
12/21/2007CA2651679A1 Pharmaceutical composition with synergistic anticonvulsant effect
12/21/2007CA2649982A1 Formulation comprising whey protein and hydrolysates for improving muscle recovery
12/20/2007US20070293937 Endoluminal medical device for local delivery of cathepsin inhibitors, method of making and treating
12/20/2007US20070293566 Combinations of vanadium with antidiabetics for glucose metabolism disorders
12/20/2007US20070293453 Combinatorial Methods For Inducing Cancer Cell Death
12/20/2007US20070293451 Regulation ao ApoB by Hsp110 proteins and related compositions and methods
12/20/2007US20070293450 Identification of ses-3 and the uses of same
12/20/2007US20070293442 Antithrombotic compound
12/20/2007US20070293438 Antibody specifically binding to sulfonylated protein protein and method for producing the same
12/20/2007US20070293437 Expression Profiling Platform Technology
12/20/2007US20070293436 Cytoprotective thereapeutic agents for the prevention of reperfusion injury following ischemic stroke
12/20/2007US20070293435 Identification and Use of Non-Peptide Analogs of RNAIII-Inhibiting Peptide for the Treatment of Staphylococcal Infections
12/20/2007US20070293434 Binding polypeptides and methods based thereon
12/20/2007US20070293433 Methods of treating aging of skin with oligosaccharides in cosmetic or dermatological compositions that stimulate adhesion of keratinocytes to major proteins of the dermoepidermal junction and restore epidermal cohesion
12/20/2007US20070293432 Stable ophthalmic formulations; include a stable liquid formulation and a lyophilizable formulation
12/20/2007US20070293431 Method for improving neurotransmission failure using a novel agent
12/20/2007US20070293430 Mutein of human FGF-21 containing an engineered disulfide where cysteine replaces leucine 118 and alanine 134, alanine for serine 167; reduced deamidation and capacity of O-glycosylation compared to wild-type human FGF-21; antidiabetic agents, type 2 diabetes; obesity; metabolic syndrome
12/20/2007US20070293429 Pituitary adenylate cyclase activating peptide; solid phase synthesis; diabetes, insulin resistance, metabolic acidosis and obesity
12/20/2007US20070293428 Methods of treating joint pain in a subject by using an anti-angiogenic agent
12/20/2007US20070293427 Glycosaminoglycans; food complements, medicaments; joint pain, obesity; bioavailability
12/20/2007US20070293426 Methods for improving islet signaling in diabetes mellitus and for its prevention
12/20/2007US20070293425 Mutein of a Bone Morphogenetic Protein and Use Thereof
12/20/2007US20070293424 Antitumoral and Antiviral Peptides
12/20/2007US20070293423 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide
12/20/2007US20070293422 Beta-Amyloid Inhibitors and Use Thereof
12/20/2007US20070293421 Erythropoietin for Treatment of Multi-Organ Failure
12/20/2007US20070293420 Enrichment of erythropoietin from a culture supernatant produced by culturing eukaryotic host cells followed by at least 5 chromatographic purification steps
12/20/2007US20070293419 Stable, Aqueous Solution of Human Erythropoietin, Not Containing Serum Albumin
12/20/2007US20070293418 Therapeutic amino acid sequences for use in treatment and prevention of viral, infectious, cancerous, diabetic, incontinent, hypertensive and nervous system disorders
12/20/2007US20070293417 Polyamides for treating human papilloma virus
12/20/2007US20070293415 Composition Containning Flavan Compound
12/20/2007US20070292933 Inhibitors of serine proteases, particular HCV NS3-NS4A protease
12/20/2007US20070292920 Neurotoxins with enhanced target specificity
12/20/2007US20070292904 Ephrin and EPH receptor mediated immune modulation
12/20/2007US20070292885 Human cdnas and proteins and uses thereof
12/20/2007US20070292546 Use of Botulinum Toxin for Preparing a Drug for Preventing Hair Growth
12/20/2007US20070292520 Pulmonary Insulin Crystals
12/20/2007US20070292514 Bioengineered Intervertebral Discs and Methods for Their Preparation
12/20/2007US20070292512 Solid Oral Dosage Form Containing an Enhancer
12/20/2007US20070292507 Supportive Treatment of Liver Disease
12/20/2007US20070292506 Sustained release formulations
12/20/2007US20070292496 Formulation of liposomal vesicles in aqueous solutions with lachrymal film characteristics
12/20/2007US20070292494 Carbohydrate-Derivatized Liposomes for Targeting Cellular Carbohydrate Recognition Domains of Ctl/Ctld Lectins, and Intracellular Delivery of Therapeutically Active Compounds
12/20/2007US20070292490 Production of tissue factor in plants
12/20/2007US20070292478 Medical Implant Provided with Inhibitors of Atp Synthesis
12/20/2007US20070292474 A scaffold of biodegradable biopolymers including a combination of either collagen or gelatin and either chondroitin-6-sulfate, chondrotin-4-sulfate, heparin, heparan sulfate, keratan sulfate, dermatan sulfate, chitin, or chitosan; tissue engineering; glaucoma; antiscarring agents; kits; druug-free
12/20/2007US20070292473 Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parenteral administration and preparation process
12/20/2007US20070292456 Formulations Containing an Immune Response Modifier
12/20/2007US20070292454 Therapeutic calcium phosphate particles and methods of manufacture and use
12/20/2007US20070292449 Long peptides of 22-45 amino acid residues that induce and/or enhance antigen specific immune responses
12/20/2007US20070292444 Peptides for treatment and diagnosis of bone diseases
12/20/2007US20070292443 Polypeptides with multifunction
12/20/2007US20070292441 Tumor Specific Antibody
12/20/2007US20070292440 CD154 blockade therapy for pancreatic islet tissue transplantation
12/20/2007US20070292437 Chlamydia PMP Proteins, Gene Sequences and Uses Thereof
12/20/2007US20070292436 Immunogenic proteoliposomes, and uses thereof
12/20/2007US20070292435 Polypeptide for use in the treatment of tumors, autoimmune, inflammatory and viral diseases; graft vs. host disease
12/20/2007US20070292433 Compounds and methods for treatment of chemotherapy-induced anemia
12/20/2007US20070292431 4-1Bb Receptors are Expressed on Regulatory T-Cells
1 ... 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 ... 3163